俄罗斯宣布成功研发新冠疫苗, 黄金失守1900美元!

In 每日市场分析
August 12, 2020

俄罗斯宣布成功研发新冠疫苗
俄罗斯传媒报道,总统普京宣布已成为全球首个注册针对新冠疫苗的国家,并希望能够在不久将来开始大量生产,预期疫苗至明年 1 月 1 日可供民用。当地衞生部长表示,疫苗於 6 月 18 日启动临床试验,所有 38 名参与志愿者,均产生了免疫力,反映疫苗的高效性及安全性。又指短期内将继续进行有数千人参与的临床测试,新冠病毒疫苗研发取得重大进展,增加近期处於高位黄金的调整压力,并一举失守10 及 20 天平均线支持,技术上进入整固走势。

黄金失守1900美元!
周二黄金下跌近130美元,跌幅5.7%,为7年来最大水平,并在周三进一步扩大跌幅,跌破1900美元,刷新近3周低点至1889.84美元。随着周二俄罗斯注册全球首个新冠疫苗的消失,全球出现了一波贵金属抛售狂潮。

————————————
Z. com Bullion为日本上市集团GMO Financial Holdings, Inc 旗下关联公司。杠杆式保证金交易存在高风险 , 有关风险请浏览公司网站https://bullion.z.com/tc/about/legal/risk/

場外式黃金/白銀交易的風險:
Service relating to Over-the-counter (OTC) Gold Bullion/Silver trading is provided by MOL. OTC Gold/Silver Bullion trading carries a high degree of risk and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. OTC Gold/Silver Bullion is not regulated by the Securities and Futures Commission (""SFC"") and therefore trading OTC Gold/Silver Bullion will not be subject to rules or regulations promulgated by the SFC. Before deciding to trade OTC Gold/Silver Bullion you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain losses in excess of your deposited fund or even more in extreme circumstances and therefore, you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading OTC Gold/Silver Bullion, and seek advice from an independent financial advisor if you require.